B. Summy Amy's most recent trade in Laboratory Corp. Of America Holdings was a trade of 2,077 Common Stock done . Disclosure was reported to the exchange on March 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 2,077 | 6,621 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 231.67 per share. | 27 Mar 2025 | 758 | 5,301 (0%) | 0% | 231.7 | 175,606 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.67 per share. | 27 Mar 2025 | 562 | 6,059 (0%) | 0% | 231.7 | 130,199 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 250.40 per share. | 24 Feb 2025 | 226 | 4,544 (0%) | 0% | 250.4 | 56,590 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,100 | 2,100 | - | - | Non-qualified Stock Options | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 690 | 1,560 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 201 | 4,825 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 201 | 1,359 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.15 per share. | 11 Feb 2025 | 55 | 4,770 (0%) | 0% | 245.1 | 13,483 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 224 | 4,692 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 224 | 870 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 223 | 1,094 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 223 | 4,541 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 73 | 4,468 (0%) | 0% | 247.7 | 18,085 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.26 per share. | 06 Feb 2025 | 68 | 4,624 (0%) | 0% | 246.3 | 16,746 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 4,015 | 0 | - | - | Non-qualified Stock Options | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 168.52 per share. | 22 Nov 2024 | 4,015 | 7,990 (0%) | 0% | 168.5 | 676,608 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 238.94 per share. | 22 Nov 2024 | 3,671 | 4,318 (0%) | 0% | 238.9 | 877,142 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 217.29 per share. | 01 Apr 2024 | 3,500 | 3,975 (0%) | 0% | 217.3 | 760,515 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 5,778 | 1,317 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 5,778 | 9,637 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 2,162 | 7,475 (0%) | 0% | 216.6 | 468,224 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 218.45 per share. | 07 Mar 2024 | 227 | 3,859 (0%) | 0% | 218.4 | 49,588 | Common Stock |
| Labcorp | Amy Summy B. | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 201 | 7,095 | - | - | Restricted Stock Unit | |
| Labcorp | Summy Amy B. | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 201 | 4,152 (0%) | 0% | - | Common Stock | |
| Labcorp | B. Amy Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 66 | 4,086 (0%) | 0% | 227.5 | 15,012 | Common Stock |
| Labcorp | Amy Summy B. | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 2,100 | 2,100 | - | - | Non-qualified Stock Options | |
| Labcorp | Summy Amy B. | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 670 | 7,520 | - | - | Restricted Stock Unit | |
| Labcorp | Summy B. Amy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 4,024 (0%) | 0% | - | Common Stock | |
| Labcorp | Summy B. Amy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 7,296 | - | - | Restricted Stock Unit | |
| Labcorp | B. Summy Amy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 73 | 3,951 (0%) | 0% | 223.7 | 16,331 | Common Stock |
| Labcorp | Amy Summy B. | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 246 | 6,850 | - | - | Restricted Stock Unit | |
| Labcorp | Summy B. Amy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 246 | 3,880 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 80 | 3,800 (0%) | 0% | 221.5 | 17,723 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 5,824 | 7,004 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 3,234 | 4,903 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 1,269 | 3,634 (0%) | 0% | 224.7 | 285,144 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,340 | 1,180 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,340 | 2,043 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.46 per share. | 02 Mar 2023 | 374 | 1,669 (0%) | 0% | 239.5 | 89,558 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 180 | 757 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 180 | 2,520 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 54 | 703 (0%) | 0% | 248.1 | 13,399 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 1,900 | 1,900 | - | - | Non-qualified Stock Options | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 600 | 2,700 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 267 | 2,100 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 267 | 660 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.51 per share. | 04 Feb 2023 | 83 | 577 (0%) | 0% | 244.5 | 20,294 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 220 | 470 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 220 | 2,367 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.99 per share. | 02 Feb 2023 | 77 | 393 (0%) | 0% | 255.0 | 19,634 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 262.21 per share. | 10 Mar 2022 | 249 | 250 (0%) | 0% | 262.2 | 65,290 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 1,900 | 1,900 | - | - | Non-qualified Stock Options | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 540 | 2,587 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 267 | 582 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 267 | 2,047 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.48 per share. | 04 Feb 2022 | 83 | 499 (0%) | 0% | 277.5 | 23,031 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 220 | 2,314 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 220 | 392 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.18 per share. | 02 Feb 2022 | 77 | 315 (0%) | 0% | 273.2 | 21,035 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 266 | 266 (0%) | 0% | - | Common Stock | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 266 | 2,534 | - | - | Restricted Stock Unit | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.78 per share. | 04 Feb 2021 | 94 | 172 (0%) | 0% | 223.8 | 21,035 | Common Stock |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 2,300 | 2,300 | - | - | Non-qualified Stock Options | |
| Labcorp | Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 660 | 2,800 | - | - | Restricted Stock Unit |